Menu

Milestones

2017
May 2017

New Company!

New Company!

John Nealon and Dr. David Staskin form UroCure and secure intellectual property from Endo/AMS.

Read More
December 2017

Series A Fundraising

Series A Fundraising

UroCure raises $2.8M in Series A funding to finance the development of its first product, the ArcTV Sling System.

2019
January 2019

First Patient Device Card

First Patient Device Card

UroCure announces the ArcTV Patient Device Card, the industry’s first patient device card given to patients after their sling procedure. This provides the patient with the name, sling type, and device lot (tracking) number specific to her sling.

Read More

February 2019

FDA Clearance

FDA Clearance Milestone

UroCure receives FDA 510(k) clearance on its first product, the ArcTV Sling System.

March 2019

Quality & Oversight Committee

Quality Oversight Committee

UroCure establishes the first Quality and Safety Oversight Committee (QSOC) in women’s health, comprised of leading academic experts in urogynecology and female urology.

Read More

April 2019

ACQUIRE Registry

ACQUIRE Registry

UroCure announces partnering sponsorship with the American Urogynecologic Society (AUGS) for their ACQUIRE Registry to track patient outcomes with the ArcTV sling. Through their sponsorship, UroCure demonstrates its support for the society’s efforts to achieve quality patient outcomes and build transparency and trust among physicians, regulatory agencies, and industry.

Read More

July 2019

First Procedure

First Procedure Milestone

Surgeons at Mt. Auburn Hospital—a Harvard Medical School teaching hospital–completes the first ArcTV Sling procedure.

Read More

2020
January 2020

Series B Fundraising

Series B Funding

Company announces completion of Series B funding of $1.8M, including $1M bridge financing.

2021
September 2021

New Partnership with LiNA Medical USA

New Partnership with LiNA Medical USA

UroCure and LiNA Medical announce a sales distribution and product development partnership that leverages the strengths of both companies.